69,1 mmol/mol) or very high cardiovascular risk, and the regimen should include an SGLT-2 inhibitor and/or a GLP-1 receptor agonist ( 1c 1.52.0% above target, especially when therapies with high glycemic efficacy and proven cardiovascular or renal benefit are indicated ( 1c (11.6%, 102.6 mmol/mol), BMI 32.6 kg/m 2 , hypertension, proteinuria, fulfilling criteria for early combination therapy under both sets of guidelines
A study conducted on an animal model revealed that similarly to vitamin D, the benefits of selenium supplementation are largely influenced by baseline selenium concentration (250)
Approved health claims: Vitamin B12 contributes to normal energy-yielding metabolism and reduction of tiredness and fatigue, Vitamin B12 contributes to the reduction of tiredness and fatigue Calcium contributes to normal muscle function, Calcium contributes to normal energy-yielding metabolism Calcium Alpha-Ketoglutarate (Ca-AKG) Rejuvenation study in humans showed reduced biological aging markers over 7 months Study L-Carnitine Meta-analysis shows benefits for physical performance and recovery Study Coenzyme Q10 (Ubiquinone) Shown to support mitochondrial function and reduce fatigue Study These ingredients are studied individually but their combined effect lies in how they support the same energy system
Its like a rubber bandyou pull it hard and it snaps back quickly. For that reason, clinicians typically counsel patients that GLP-1 medications are a long-term treatment, similar to medications for high blood pressure or diabetes
